...
首页> 外文期刊>Experimental Neurology >Effect of allogeneic Schwann cell transplantation on peripheral nerve regeneration.
【24h】

Effect of allogeneic Schwann cell transplantation on peripheral nerve regeneration.

机译:同种异种雪旺细胞移植对周围神经再生的影响。

获取原文
获取原文并翻译 | 示例

摘要

Transplantation of allogeneic Schwann cells (SC) would make it feasible to reconstruct immediately peripheral nerve defects, compared to using autologous SC; however, this treatment modality has not been adequately evaluated. The aim of this study was to characterize and compare the effects of allogeneic versus syngeneic SC transplantation following peripheral nerve injury. Polyhydroxybutyrate conduits were used to bridge a 10-mm gap in the rat sciatic nerve. The conduits were filled with alginate hydrogel with or without cultured allogeneic or syngeneic genetically labeled SC, without the use of immunosuppressive therapy, and examined after 2, 3, and 6 weeks with 5-bromo-4-chloro-3-indoyl-beta-D-galactosidase chemical staining and immunohistochemistry to quantify SC migration into the conduit, axonal regeneration, the state of SC differentiation, and the expression of major histocompatibility complexes (MHC) I and II, as well as to quantify macrophage and B- and T-lymphocyte infiltration. Allogeneic SC were rejected by 6 weeks, whereas syngeneic SC could still be identified. Allogeneic and syngeneic SC equally enhanced the axonal regeneration distance but the quantity of axons was greater using syngeneic SC. The ingrowth of SC into the conduits containing allogeneic SC was similar to that observed in the presence of syngeneic SC, indicating the absence of deleterious immune response. SC continued to express phenotypic markers of nonmyelination and these were highest in conduits with allogeneic SC. Expression of MHC I and II was higher in the conduits with allogeneic SC at 3 weeks and without significant difference in the number of macrophages and lymphocytes, except at 6 weeks, when there was a larger number of lymphocytes using syngeneic SC. In conclusion, allogeneic SC enhanced axonal regeneration distance and did not induce a deleterious immune response. In a clinical setting the immediate availability of allogeneic SC for transplantation may compensate for the better outcome achieved by the use of autologous SC that require a longer preparation time in culture.
机译:与使用自体SC相比,同种异体雪旺细胞(SC)的移植将使立即重建周围神经缺损变得可行。但是,这种治疗方式尚未得到充分评估。这项研究的目的是表征和比较同种异体与同种SC移植在周围神经损伤后的效果。使用聚羟基丁酸酯导管弥合大鼠坐骨神经中的10毫米间隙。在不使用免疫抑制疗法的情况下,将导管填充有藻酸盐水凝胶,藻酸盐水凝胶有或没有培养同种异体或同基因遗传标记的SC,并在2、3和6周后用5-溴-4-氯-3-吲哚基-β- D-半乳糖苷酶化学染色和免疫组化,以定量SC迁移进入导管,轴突再生,SC分化状态以及主要组织相容性复合物(MHC)I和II的表达,以及定量巨噬细胞以及B-和T-淋巴细胞浸润。异基因SC在6周前被拒绝,而同基因SC仍然可以被鉴定。同种异体SC和同系SC均等地增加了轴突再生距离,但使用同系SC轴突的数量更大。 SC在含有同种异体SC的导管中的向内生长类似于在同基因SC的存在下观察到的现象,表明不存在有害的免疫应答。 SC继续表达非髓鞘化的表型标记,这些标记在同种异体SC的导管中最高。同种异体SC的导管在3周时MHC I和II的表达较高,除了6周时,当使用同基因SC的淋巴细胞数量较多时,巨噬细胞和淋巴细胞的数量没有显着差异。总之,同种异体SC可以增加轴突的再生距离,并且不会诱导有害的免疫反应。在临床环境中,同种异体SC的即时可移植性可能弥补了使用自体SC所需的更好的结果,而自体SC需要更长的培养时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号